
51 - 200 employees
Founded 2014
🧬 Biotechnology
⚕️ Healthcare Insurance
💊 Pharmaceuticals
Biotechnology • Healthcare Insurance • Pharmaceuticals
ORIC Pharmaceuticals Inc. is a biopharmaceutical company dedicated to targeting resistance mechanisms in cancer treatment to improve patients' lives. The company aims to discover, develop, and commercialize innovative therapies that address cancer resistance, enhancing the effectiveness and duration of current oncology treatments. ORIC's research focuses on various forms of resistance, including innate, acquired, and bypass resistance, and is actively conducting clinical trials for its leading therapies, ORIC-114 and ORIC-944.
🕒 May 27
Senior Director of Medical Affairs at ORIC Pharmaceuticals driving medical strategy and execution for oncological therapies. Building key global capabilities and leading scientific engagement activities.
🕒 February 27
Senior Manager, Pharmacovigilance overseeing global safety regulations and compliance for oncology products. Managing teams to support clinical trials and post-marketing activities in a biopharmaceutical company.